Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Pension (2016 - 2025)

Gsk has reported Pension over the past 11 years, most recently at $2.2 billion for Q4 2025.

  • Quarterly results put Pension at $2.2 billion for Q4 2025, down 6.21% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (down 6.21% YoY), and the annual figure for FY2025 was $2.2 billion, down 6.21%.
  • Pension for Q4 2025 was $2.2 billion at Gsk, down from $2.4 billion in the prior quarter.
  • Over the last five years, Pension for GLAXF hit a ceiling of $4.2 billion in Q4 2021 and a floor of $2.2 billion in Q4 2025.
  • Median Pension over the past 5 years was $2.9 billion (2023), compared with a mean of $3.0 billion.
  • Biggest five-year swings in Pension: fell 27.91% in 2022 and later decreased 3.99% in 2023.
  • Gsk's Pension stood at $4.2 billion in 2021, then fell by 27.91% to $3.0 billion in 2022, then decreased by 3.99% to $2.9 billion in 2023, then fell by 17.62% to $2.4 billion in 2024, then fell by 6.21% to $2.2 billion in 2025.
  • The last three reported values for Pension were $2.2 billion (Q4 2025), $2.4 billion (Q4 2024), and $2.9 billion (Q4 2023) per Business Quant data.